In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval ...

Viking Therapeutics reports positive top-line results from phase 2 VENTURE-Oral Dosing trial of VK2735 tablet formulation in patients with obesity: San Diego Wednesday, August 20, ...